Literature DB >> 18592046

[Prevalence of Obsessive Compulsive Disorder and its comorbidity with Major Depressive Disorder in adolescent students].

Germán Eduardo Rueda-Jaimes1, Paul Anthony Camacho López, Alvaro Andrés Navarro-Mancilla.   

Abstract

INTRODUCTION: at least two-thirds of the adolescents with Obsessive Compulsive Disorder have another psychiatric disorder. The objective of this study was to estimate the prevalence of Obsessive Compulsive Disorder and Major Depressive Disorder in adolescent students and its comorbidity.
METHODS: 390 adolescents were performed a structured clinical interview, clinical version: Obsessive Compulsive Disorder and Major Depressive Disorder modules. The inquired sociodemographic factors were analyzed with bivariate and multivariate statistical analysis and with non conditional logistic regression.
RESULTS: Obsessive Compulsive Disorder was 7.63, its comorbility with major depressive disorder was 48.27 and there was an association between both disorders (OR 6.6 IC 3.45 - 12.61); Major Depressive Disorder prevalence was 11.7; when we controlled confusing variables in women we found that work (OR 3,14), age (OR 1,45) and major depressive disorder (OR 3,88), showed higher risk of having Obsessive Compulsive Disorder; in contrast with the men just Major Depressive Disorder showed higher risk of having obsessive compulsive disorder (OR 10,88).
CONCLUSIONS: the Obsessive Compulsive Disorder and Major Depressive Disorder prevalence and its association in adolescent students are high; age and work could be a risk factor of having Obsessive Compulsive Disorder.

Entities:  

Mesh:

Year:  2008        PMID: 18592046

Source DB:  PubMed          Journal:  Vertex        ISSN: 0327-6139


  2 in total

1.  [Validation of two short versions of the Centre for Epidemiological Studies Depression Scale in Colombian adolescents].

Authors:  German Eduardo Rueda-Jaimes; Paul Anthony Camacho López; Andrés Mauricio Rangel-Martínez-Villalba
Journal:  Aten Primaria       Date:  2009-05-08       Impact factor: 1.137

2.  Efficacy of Botox versus Placebo for Treatment of Patients with Major Depression.

Authors:  Abbas Zamanian; Atefeh Ghanbari Jolfaei; Golnaz Mehran; Zahra Azizian
Journal:  Iran J Public Health       Date:  2017-07       Impact factor: 1.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.